Share >  
Share
Share on Tumblr

Shailendra Bhatnagar

News »

   latest by relevance
GS Case: SC stays cost recovery imposed by SAT on Sebi
Sep 01, 2008 at 11:35 | Source: CNBC-TV18
The SC has stayed the recovery of cost imposed by the SAT on the Sebi in the Goldman Sachs case. The SC has issued a notice on the power of the SAT to impose cost on the Sebi. The SC has questioned that why should not the observation against the adjudicating officer be expunged.
Govt may appoint 3G auctioneer by 1st week of Oct
Aug 29, 2008 at 20:44 | Source: CNBC-TV18
India will soon see the auction of frequencies for 3G services who enable users to download data at much faster speeds. Department of Telecommunications Secretary, Siddharth Behura told CNBC-TV18 that the government could be in a position to appoint a company by September 30 or the first week of October to auction 3G service frequencies.
Citigroup may sell 4.52% in Jubilant Organosys: Srcs
Aug 26, 2008 at 11:57 | Source: CNBC-TV18
There is some some noise in the market regarding a possibility of a stake sale on pharma company Jubilant Organosys. Citigroup has planned to sell its 4.52% stake in Jubilant Organosys, reports CNBC-TV18 quoting sources.
Idea Cellular dials into Mumbai circle
Aug 20, 2008 at 13:21 | Source: CNBC-TV18
Idea Cellular has dialed into the Mumbai circle today. Idea will launch with initial network of over 1,000 sites in Mumbai. It will offer 2G mobile technology with 2.75G capabilities and edge. Idea Cellular has added Mumbai to existing 11 circles.
TRAI issues recommendations for MVNO
Aug 06, 2008 at 15:31 | Source: CNBC-TV18
The TRAI has issued recommendations for MVNO. MVNOs would be issued a license under Indian Telegraph Act. It will introduce MVNOs as a service provider with own licensing framework. TRAI has permitted the MVNO model for 2G and 3G wireless broadband services. It has permitted 74% FDI cap in MVNOs.
No problems with Eli Lily tie-up: Glenmark
Aug 01, 2008 at 22:05 | Source: CNBC-TV18
There have been rumors circulating in the market about problems that Glenmark Pharma is facing with its tie-up with Eli Lily and the difficulties that the company is having in its clinical trials for various molecules. Glenn Saldhana, MD, Glenmark said, There is no truth in these allegations. "

Videos »
GS Case: SC stays cost recovery imposed by SAT on Sebi
Govt may appoint 3G auctioneer by 1st week of Oct
Idea Cellular dials into Mumbai circle
TRAI issues recommendations for MVNO
No problems with Eli Lily tie-up: Glenmark
more »

Photos »

  /  

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window